A Primer on What’s to Come at Process Simulation on February 20
- Posted by Aaron Hubbell
- On February 10, 2020
The high costs of cutting-edge biopharmaceutical treatments have captured the attention of the press, politicians, and the overall public. In particular, this recent first wave of commercial cell therapy treatments has hit and even exceeded the half-million-dollars-per-treatment mark. Pricing of novel therapies is not a new concern, but with the staggering price tags of cell […]
Read More